Floatz logo

Therapeutic Asset Ratings

534 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Clsp-1025
Cancer
Clasp Therapeutics, Inc.P1C (36)
Clsp-5282
Cancer
Clasp Therapeutics, Inc.P1C (36)
cs5001
Cancer
CStone PharmaceuticalsP1C (36)
cx1003
Cancer
Beijing Konruns Pharmaceutical Co., Ltd.P1C (36)
Datopotamab Deruxtecan
Cancer
Daiichi SankyoP1C (36)
Dcc-3084
Cancer
Deciphera Pharmaceuticals, LLCP1C (36)
Denikitug
Cancer
Gilead SciencesP1C (36)
dl4
Advanced Solid Tumor
Sun Pharma Advanced Research Company LimitedP1C (36)
dm919
Cancer
D2M Biotherapeutics Inc.P1C (36)
dnp002
Cancer
Kumho HT Inc.P1C (36)
do-2
Cancer
DeuterOncologyP1C (36)
Drug: Bg-T187
Cancer
BeOne MedicinesP1C (36)
Drug B Utidelone
Cancer
Beijing Biostar Pharmaceuticals Co., Ltd.P1C (36)
ds-1103a
Cancer
Daiichi SankyoP1C (36)
ds-1471a
Cancer
Daiichi Sankyo Co., Ltd.P1C (36)
ds5361b
Cancer
Daiichi SankyoP1C (36)
Dual-Targeting Cldn18.2 And Pd-L1 Car-T Cells
Advanced Solid Tumor
Sichuan UniversityP1C (36)
Elacestrant
Cancer
BeOne MedicinesP1C (36)
Elzovantinib
Cancer
Turning Point Therapeutics, Inc.P1C (36)
Emb-09
Cancer
Shanghai EpimAb Biotherapeutics Co., Ltd.P1C (36)
eoc237
Cancer
Shanghai Yiteng Jingang Bio-pharmaceutical Technology Co., LtdP1C (36)
Erx-315
Cancer
EtiraRx Australia Pty LtdP1C (36)
et0038
Cancer
Etern BioPharma (Shanghai) Co., LtdP1C (36)
et0111
Cancer
Etern BioPharma (Shanghai) Co., LtdP1C (36)
fp002
Cancer
Guangdong Fapon Biopharma Inc.P1C (36)
Showing 326 to 350 of 534 assets
PreviousPage 14 of 22Next